BIOTEST AG VZ
BIOTEST AG VZ (DELISTED)
Share · DE0005227235 · 522723 (XFRA)
Overview Financial Indicators
28,40 EUR
-3,40 % -1,00 EUR
Frankfurt (XETR) · Current prices and charts at MoneyPeak
06.06.2025 15:10

Current Prices from BIOTEST AG VZ

ExchangeTickerCurrencyLast TradePriceDaily Change
XETR: XETRA
XETRA
BIO3.DE
EUR
06.06.2025 15:10
28,40 EUR
29,40 EUR
-3,40 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,00 % -5,33 % -3,07 % 6,37 % 9,23 % 38,54 %

Company Profile for BIOTEST AG VZ Share

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and IgG Next Genration for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B re-infection prophylaxis after liver transplantation. In addition, it provides Albiomin and Biseko to restore and maintain circulating blood volume; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. The company was founded in 1946 and is headquartered in Dreieich, Germany. As of January 21, 2022, Biotest Aktiengesellschaft operates as a subsidiary of Grifols, S.A.

Company Data

Name BIOTEST AG VZ
Company Biotest AG
Website https://www.biotest.com
Primary Exchange XFRA Frankfurt
WKN 522723
ISIN DE0005227235
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Peter Janssen
Market Capitalization 1 Mrd.
Country Germany
Currency EUR
Employees 2,5 T
Address Landsteinerstrasse 5, 63303 Dreieich
IPO Date 1998-11-17
Dividends from 'BIOTEST AG VZ'
Ex-Date Dividend per Share
08.05.2024 0,08 EUR
06.05.2022 0,04 EUR
12.05.2021 0,04 EUR
11.05.2020 0,04 EUR
08.05.2019 0,04 EUR
16.05.2018 0,04 EUR
31.08.2017 0,07 EUR
13.05.2016 0,04 EUR
08.05.2015 0,66 EUR
08.05.2014 0,63 EUR

Ticker Symbols

Name Symbol
Frankfurt BIO3.F
XETRA BIO3.DE

More Shares

Investors who BIOTEST AG VZ hold also have the following shares in their portfolio:
NORTH.STAR 23/33 REGS
NORTH.STAR 23/33 REGS Bond
Notable Labs, Ltd. - Ordinary Shares
Notable Labs, Ltd. - Ordinary Shares Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025